Diploma (LON:DPLM) Shares Cross Above Two Hundred Day Moving Average of $3,316.85

Shares of Diploma PLC (LON:DPLM) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 3,316.85 ($40.97) and traded as high as GBX 3,594 ($44.39). Diploma shares last traded at GBX 3,542 ($43.75), with a volume of 163,216 shares.

Analyst Upgrades and Downgrades

Several research firms have commented on DPLM. Shore Capital reissued a “buy” rating on shares of Diploma in a research report on Wednesday, March 27th. Berenberg Bank upped their price objective on shares of Diploma from GBX 3,800 ($46.94) to GBX 4,400 ($54.35) and gave the stock a “buy” rating in a report on Thursday, March 28th.

Diploma Trading Up 0.5 %

The company has a current ratio of 2.06, a quick ratio of 0.80 and a debt-to-equity ratio of 44.05. The company’s fifty day moving average is GBX 3,480.20 and its 200-day moving average is GBX 3,316.85. The firm has a market capitalization of £4.77 billion, a P/E ratio of 3,935.56, a P/E/G ratio of 2.82 and a beta of 0.73.

Diploma Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, February 2nd. Investors of record on Thursday, January 18th were issued a dividend of GBX 40 ($0.49) per share. This is an increase from Diploma’s previous dividend of $16.50. This represents a dividend yield of 1.32%. The ex-dividend date of this dividend was Thursday, January 18th. Diploma’s dividend payout ratio is currently 6,333.33%.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.